BioPharmics

#3D modelling #Artificial intelligence (AI) #BioPharmics #Computational chemistry #Mergers and acquisitions #Molecular Biology #Optibrium

Optibrium acquires BioPharmics

AI drug discovery company Optibrium has acquired 3D drug design specialist BioPharmics. BioPharmics’ CEO, Dr Ajay Jain, and Director of Applied Science, Dr Ann Cleves, will join the Optibrium team, respectively focusing on R&D and Application Science in the newly-created BioPharmics Division. BioPharmics has developed a series of algorithms and… Read More

#Business & Investment #News